A closer look at the hormone pathway.
Sermorelin is a synthetic growth hormone-releasing hormone (GHRH) analogue. Learn how it works and what to consider before treatment.
Compare treatments
Sermorelin is a synthetic analogue of growth-hormone-releasing hormone. It signals the pituitary gland to release growth hormone. Because this is a distinct hormone pathway, any discussion should begin with careful evaluation rather than broad wellness promises.
Research shows sermorelin can stimulate growth hormone release. That mechanism should not be translated into claims about fat loss, muscle gain, sleep, recovery or anti-aging. More research is needed to understand its clinical effects in adults and to determine who may benefit.
Sermorelin binds to receptors in the pituitary gland and stimulates the body’s own release of growth hormone. That mechanism should not automatically be translated into claims about fat loss, muscle gain, sleep, recovery, anti-aging, or weight loss.
A licensed provider reviews your health history, goals and relevant clinical factors to determine if sermorelin is appropriate for you.
Sermorelin does not have a current FDA-approved indication for weight loss. Historical approvals were for different pediatric uses, and compounded formulations are not FDA approved.
No. Sermorelin is an analogue of a releasing hormone that signals the pituitary gland; it is not growth hormone itself.
No. It should be considered separately from medications specifically used for chronic weight management.
A responsible review would consider the intended use, exact product, evidence, potential risks, sourcing, monitoring needs, and your individual health history.
